Local News

• Corn farmers who use Monsanto advanced technology eligible for lower insurance premiums  Farmers in 11 states who plant a majority of their corn acres using hybrid seeds featuring YieldGard Plus with Roundup Ready Corn 2, YieldGard VT Triple and YieldGard VT Triple PRO technology from Monsanto Company will have an opportunity to lower their crop insurance premiums in 2009.
  Monsanto Company August 19, 2008  
• Patient side point-of-care testing enables quicker treatment decisions  Patient side point-of-care testing - where diagnostic testing is conducted at or near the site of the patient - enables doctors to make decisions on patients presenting with chest pain up to 20 minutes faster than those whose lab tests are evaluated by a standard lab.
  Abbott August 19, 2008  
• BMS and PDL BioPharma enter alliance to develop novel treatment for multiple myeloma  Bristol-Myers Squibb Company and PDL BioPharma announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzumab, previously known as HuLuc63, currently in Phase I development for multiple myeloma.
  Bristol-Myers Squibb Company August 19, 2008  
• Snakes alive: Hiberna seeks help from nature to cure many diseases  Hiberna's Leslie Leinwand thinks that pythons and ground squirrels can benefit mankind. The Boulder-based startup is researching the metabolism of Burmese pythons and the hibernation of ground squirrels to develop drugs.
  Denver Business Journal August 15, 2008  Bob Mook
• Abbott and AstraZeneca expand relationship to include co-promotion of CRESTOR(R)  Abbott and AstraZeneca announced that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR(R) (rosuvastatin calcium), a medication used along with diet to reduce high cholesterol.
  Abbott August 14, 2008  
• BSD Medical provides to FDA data requested for MicroThermX-100 Microwave Ablation System  BSD Medical announced that the company has provided to the Food and Drug Administration (FDA) additional data requested pertaining to its 510(k) Premarket Notification submission for the MicroThermX-100 Microwave Ablation System.
  BSD Medical Corporation August 14, 2008  
• Pfizer says vacation with your dog before the summer ends  With canine motion sickness the leading reason pet owners are not able to take their dogs on day trips or vacation, Pfizer is encouraging more people to talk with their veterinarians about managing travel with their dog before the summer ends.
  Pfizer Inc. August 14, 2008  
• OrthoLogic announces completion of dosing for second AZX100 Phase 1  OrthoLogic announced the completion of dosing for its second AZX100 Phase 1 human clinical trial in dermal/hypertrophic scarring. Patient follow-up is ongoing.
  OrthoLogic Corp. August 14, 2008  
• Spectranetics takes steps targeted at accelerating vascular intervention growth  Spectranetics announced several organizational changes within its vascular intervention (VI) business designed to strengthen its leadership team, streamline the sales management organization, and focus on new product development.
  Spectranetics Corporation August 13, 2008  
• Genentech rejects takeover bid from Roche  Roche is expected to increase its offer for the biotechnology company Genentech now that an initial $43.7 billion bid has been rejected, analysts said. Genentech said that a special committee of directors had found that Roche's offer "substantially undervalues the company."
  The New York Times August 13, 2008  Andrew Pollack

   (next 10 articles)